FDA Adverse Event Malfunction Summary report: N

ENDOBEAM SINGLE-USE HOLMIUM LASER FIBER

MDR report key: 2884786 · Received December 3, 2012

Report

Report Number
1018233-2012-01943
Event Type
Malfunction
Date Received
December 3, 2012
Report Date
November 5, 2012
Manufacturer
LASER PERIPHERALS LLC
Product Code
GEX
PMA / PMN Number
K120926
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

SAMPLE IS FORTHCOMING. THE INVESTIGATION IS STILL IN PROGRESS. THE LOT NUMBER IS UNK; THEREFORE, THE DEVICE HISTORY RECORD COULD NOT BE REVIEWED. ONCE THE SAMPLE IS RECEIVED, A SUPPLEMENTAL MDR REPORT WILL BE FILED. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISK ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE PRECAUTIONS: WHEN REMOVING THE FIBER FROM ITS POUCH OR TRAY, SECURE THE DISTAL TIP TO AVOID DAMAGE OR CONTAMINATION. DO NOT APPLY EXCESSIVE FORCE TO THE TIP OF THE FIBER AS BREAKAGE MAY RESULT. BEGIN LASING AT THE LOWEST POSSIBLE POWER/ENERGY SETTING TO ACHIEVE THE DESIRED EFFECT. USE LOWER POWER LEVELS AND SHORTER PULSES TO FAMILIARIZE YOURSELF WITH THE OPERATION OF THE BARD ENDOBEAM HOLMIUM LASER FIBER. HIGH POWER/LONG DURATION OF LASER ENERGY WHILE PLACING THE TIP IN CONTACT WITH TISSUE MAY DAMAGE OR SIGNIFICANTLY REDUCE THE LIFE OF THIS PRODUCT. DIRECT CONTACT BY LASER BEAM MAY CAUSE DAMAGE TO GUIDEWIRES, BASKETS OR OTHER URETEROSCOPIC ACCESSORIES. IF FIBER TIP IS VISIBLY DAMAGED OR REQUIRES EXCESSIVE AMOUNTS OF ENERGY TO AFFECT COAGULATION OR VAPORIZATION, DISCONTINUE USE AND REPLACE WITH A NEW FIBER FOR OPTIMUM RESULT. IF DESIRED, STRIP AND CLEAVE THE FIBER AS OUTLINED IN THE "INSTRUCTIONS FOR STRIPPING AND CLEAVING" AND "FIBER OUTPUT TEST" SECTIONS OF THIS IFU. DO NOT EXCEED THE RECOMMENDED POWER LEVELS WHEN UTILIZING THE BARD ENDOBEAM HOLMIUM LASER FIBER. CHECK THE DEVICE FOR COMPLETENESS ONCE REMOVED FROM PT. ADVERSE EVENTS: THE POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH HOLMIUM LASER FIBERS MAY INCLUDE BUT ARE NOT LIMITED TO: PERFORATION, HEMATOMA, VASOVAGAL RESPONSE, INFECTION, THERMAL DAMAGE, EDEMA, BLEEDING, DISCOMFORT, HYPERTENSION, DELAY IN HEALING, POST-PROCEDURE FEVER AND LEUKOCYTOSIS (ASSOCIATED WITH TISSUE DESTRUCTION). (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PRODUCT SNAPPED IN HALF DURING THE PROCEDURE. DEVICE REMAINED IN THE SCOPE DURING THE BREAKAGE AND WAS REMOVED WITHOUT INCIDENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOBEAM SINGLE-USE HOLMIUM LASER FIBER GEX LASER PERIPHERALS LLC NA UNK

Patients

Seq Age Sex Outcome Treatment
1